SCHEMBL6821096

SCHEMBL6821096

COC(=O)C=Cc1ccc(Cl)c(C(F)(F)F)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 4/20 0.54
TTR P02766 1/20 0.54
KDR P35968 2/20 0.52
HDAC1 Q13547 1/20 0.52
HDAC8 Q9BY41 1/20 0.52
HDAC6 Q9UBN7 1/20 0.52
PTPN1 P18031 1/20 0.51
CA12 O43570 1/20 0.50
CA1 P00915 1/20 0.50
CA2 P00918 1/20 0.50
TYR P14679 1/20 0.50
CA7 P43166 1/20 0.50
CA9 Q16790 1/20 0.50
CA14 Q9ULX7 1/20 0.50
EPHX2 P34913 1/20 0.50
KDM4E B2RXH2 3/20 0.49
ALDH1A1 P00352 3/20 0.49
MAPT P10636 2/20 0.49
JAK2 O60674 1/20 0.49
GAA P10253 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6821093 1.00 APP (0.54) APPTTRKDRHDAC1HDAC8
SCHEMBL17999148 0.86 KDR (0.47) APPTTRKDRHDAC1HDAC8
SCHEMBL17999147 0.86 KDR (0.47) APPTTRKDRHDAC1HDAC8
SCHEMBL29707575 0.86 KDR (0.47) APPTTRKDRHDAC1HDAC8
SCHEMBL3529897 0.85 APP (0.56) APPTTRPTPN1CA12CA1
SCHEMBL3536728 0.84 APP (0.52) APPTTRPTPN1CA12CA1
SCHEMBL3536725 0.84 APP (0.52) APPTTRPTPN1CA12CA1
SCHEMBL6821362 0.84 APP (0.55) APPTTRPTPN1CA12CA1
SCHEMBL6821360 0.84 APP (0.55) APPTTRPTPN1CA12CA1
SCHEMBL5219928 0.82 HDAC1 (0.53) APPTTRKDRHDAC1HDAC8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004046122-A2 BENZOXAZOLE, BENZTHIAZOLE AND BENZIMIDAZOLE ACID DERIVATIVES AND THEIR USE AS HEPARANASE INHIBITORS OXFORD GLYCOSCIENCES (UK) LTD (GB) 2004-06-03 WO disclosed
US-5489592-A ALDOSE REDUCTASE INHIBITORS FOR TREATMENT OF DIABETES-RELATED DISORDERS LIPHA, LYONNAISE INDUSTRIELLE PHARMACEUTIQUE (FR) 1996-02-06 US disclosed